AstraZeneca lead sponsor for Healthy futures: genomics and beyond
25 October 2017
AstraZeneca is a global, science-led pharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, mainly in the areas of oncology, cardiovascular & metabolic diseases and respiratory. The Company’s headquarters moved to Cambridge in May 2016.
Dr John Chevers, Head of Business Development for PHG Foundation said, 'we are delighted to have AstraZeneca associated with the conference -not only as a a world leader in precision medicine, but now as a major player in our Cambridge scientific ecosystem.'
Healthy futures: genomics and beyond will bring together professionals with an interest in aspects of genomic medicine and personalised healthcare, to explore the frontiers of modern medicine and beyond.
The conference features:
- An international line up of pioneers in personalised healthcare including Prof Dame Sally Davies (Chief Medical Officer for England), Dr Robert Green (Director, Genomes2People) and Prof Sue Hill (Chief Scientific Officer for England) plus many more
- Parallel sessions looking at the practical implications of delivering scientific innovations to health professionals and patients and a discussion of whether technology complements or contradicts the ‘personal’ in personalised healthcare
- Quick fire updates on emerging technologies that could have a massive impact on health, including liquid biopsies for cancer, biosensors, digital health and 3D printing of drugs
Healthy futures: genomics and beyond takes place on 28 November. Visit the PHG Foundation website for more information and booking.